// App-Quantinova.ai

: Recruitment procedure to maximise inclusion of progressors in OA clinical studies using subjects from existing cohorts

Researchers

Presenter

  • P. Widera

Principal Investigators

  • S. Danso

  • S. Peelen

  • F. Lafeber

  • F. Petit-Dop

  • H. Weinans

  • J. Larkin

  • L. Hussaarts

  • L. Paolozzi

  • I.K. Haugen

  • F.J. Blanco

  • M. Kloppenburg

  • F. Berenbaum

  • J. Sellam

  • W.E. van Spil

  • A. Mobasheri

  • M.C. Levesque

  • A.-C. Bay-Jensen

  • A. Tielmann

  • C. Ladel

  • J. Loughlin

  • J. Bacardit

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Univ. Med. Ctr. (UMC) Utrecht, Utrecht, Netherlands

  • Lygature,Utrecht,Netherlands

  • Servier, Suresnes, France

  • GlaxoSmithKline, King of Prussia, PA.

  • Diakonhjemmet Hospital, Oslo, Norway

  • SERGAS, A Coruña, Spain

  • Leiden U Med Ctr, Leiden, Netherlands

  • Saint Antoine Hospital, paris, France

  • University of Surrey, Guildford, United Kingdom

  • AbbVie, Chicago, IL

  • Nordic Bioscience, Herlev, Denmark

  • Merck KGaA, Darmstadt, Germany

Locations

  • United Kingdom

  • Netherlands

  • France

  • United States

  • Norway

  • Spain

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved